JP2023504233A5 - - Google Patents

Info

Publication number
JP2023504233A5
JP2023504233A5 JP2022524952A JP2022524952A JP2023504233A5 JP 2023504233 A5 JP2023504233 A5 JP 2023504233A5 JP 2022524952 A JP2022524952 A JP 2022524952A JP 2022524952 A JP2022524952 A JP 2022524952A JP 2023504233 A5 JP2023504233 A5 JP 2023504233A5
Authority
JP
Japan
Prior art keywords
approximately
mass
combination
mass ratio
quercetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022524952A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504233A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051439 external-priority patent/WO2021081634A1/en
Publication of JP2023504233A publication Critical patent/JP2023504233A/ja
Publication of JP2023504233A5 publication Critical patent/JP2023504233A5/ja
Pending legal-status Critical Current

Links

JP2022524952A 2019-10-28 2020-10-27 酸化的ストレス損傷を低減又は防止するための製剤 Pending JP2023504233A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962926953P 2019-10-28 2019-10-28
US62/926,953 2019-10-28
PCT/CA2020/051439 WO2021081634A1 (en) 2019-10-28 2020-10-27 Formulation to reduce or prevent oxidative stress damage

Publications (2)

Publication Number Publication Date
JP2023504233A JP2023504233A (ja) 2023-02-02
JP2023504233A5 true JP2023504233A5 (https=) 2023-11-06

Family

ID=75714707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022524952A Pending JP2023504233A (ja) 2019-10-28 2020-10-27 酸化的ストレス損傷を低減又は防止するための製剤

Country Status (8)

Country Link
US (1) US20220378716A1 (https=)
EP (1) EP4051261A4 (https=)
JP (1) JP2023504233A (https=)
KR (1) KR20220132522A (https=)
CN (1) CN115209892B (https=)
AU (1) AU2020376980B2 (https=)
IL (1) IL292525A (https=)
WO (1) WO2021081634A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118121587A (zh) * 2022-12-02 2024-06-04 辽宁何氏医学院 二氢槲皮素在治疗眼表疾病中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
JP2004515508A (ja) * 2000-12-16 2004-05-27 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 化合物の健康促進組成物
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
US6572897B1 (en) * 2002-07-03 2003-06-03 Vitacost.Com, Inc. Insulin sensitivity maintenance and blood sugar level maintenance formulation for the prevention and treatment of diabetes
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
US9192586B2 (en) * 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
WO2004064725A2 (en) * 2003-01-13 2004-08-05 The Quigley Corporation Oral compositions and methods for treatment of adverse effects or radiation
US7399496B2 (en) * 2003-02-07 2008-07-15 Glanbia Nutritionals (Ireland) Limited Hydrolyzed whey protein compositions
US20050112210A1 (en) * 2003-09-12 2005-05-26 Terry Grossman Eye nutritional supplement
US7585536B2 (en) * 2004-05-27 2009-09-08 Silver Barnard S Compositions of fructose and glucose containing inulin
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
US20060115554A1 (en) * 2004-12-01 2006-06-01 Slim-Fast Foods Company, Division Of Conopco, Inc. Nutrition bar
US20070082025A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for achieving and maintaining weight loss
US7976879B2 (en) * 2005-11-04 2011-07-12 Roizen Michael F Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions
CN101835449A (zh) * 2007-08-31 2010-09-15 Dsmip资产有限公司 4-脒基苄胺用于美容和/或皮肤病学的用途
US8491889B1 (en) * 2010-01-26 2013-07-23 Jayson B. Calton Method for reducing micronutrient competitions
AU2011227202A1 (en) * 2010-03-17 2012-10-04 Arbonne International Llc Oral supplement
CN102232553A (zh) * 2010-05-06 2011-11-09 袁长铭 摄养组合物质
US8344078B2 (en) * 2010-05-21 2013-01-01 Chevron Phillips Chemical Company Lp Continuous take off technique and pressure control of polymerization reactors
EP2397038A1 (en) * 2010-06-21 2011-12-21 Abbott Laboratories Early programming of brain function through soy protein feeding
US20130224281A1 (en) * 2011-04-07 2013-08-29 United States Of America As Represented By The Administrator Of The National Aeronautics & Space Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress
US20140023701A1 (en) * 2011-04-07 2014-01-23 Nugevity Llc Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress
CA2799127C (en) * 2012-12-18 2021-05-18 Matthew Bennett Compositions and methods for treating traumatic brain injury
US9101580B2 (en) * 2012-12-18 2015-08-11 Matthew Bennett Compositions and methods for treating traumatic brain injury
JP2015218140A (ja) * 2014-05-19 2015-12-07 医療法人千清會 鈴木脳神経外科 抗酸化サプリメント
JP7123945B2 (ja) * 2016-10-03 2022-08-23 シャー，ホウン・サイモン がん放射線療法を増強するための組成物および方法

Similar Documents

Publication Publication Date Title
JP2005510509A (ja) 放射線障害の予防、軽減、及び治療用の栄養性サプリメント及びその方法
US7435725B2 (en) Oral compositions and methods for prevention, reduction and treatment of radiation injury
US7410659B2 (en) Methods for the treatment of peripheral neural and vascular ailments
Choudhry et al. Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature
US20030118536A1 (en) Topical compositions and methods for treatment of adverse effects of ionizing radiation
JP2005528333A5 (https=)
AU2002309615A1 (en) Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
JP6125760B2 (ja) 皮膚を防護するためのカロチノイド組成物及び方法
CA2470603A1 (en) Methods for the treatment of peripheral neural and vascular ailments
US20030105031A1 (en) Methods for the treatment of skin disorders
ZA200403365B (en) Topical compositions and methods for treatment of adverse effects of ionizing radiation
JP2014518274A5 (https=)
JP2004516257A (ja) 糖尿病性神経障害の治療に対する組成物及びその方法
JP2004516257A5 (https=)
Vyas et al. Antioxidants in oral diseases and future prospects and their application in dentistry
JP2023504233A5 (https=)
WO2004064725A2 (en) Oral compositions and methods for treatment of adverse effects or radiation
Fan et al. Role of micronutrition in patients with oral cancer and nutritional intervention strategies
AU2020376980B2 (en) Formulation to reduce or prevent oxidative stress damage
Mufeed et al. Role of antioxidants in dentistry
US20130196934A1 (en) Composition for perinatal and neonatal stroke
CA3109188A1 (en) Comestible compositions for promoting atp synthesis
IT202000012754A1 (it) Associazione di principi attivi, composizioni che la contengono e loro uso per sostenere e rafforzare il sistema immunitario.